Works by Maniatis, Aristides

Results: 20
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication somatrogon injections were less of a burden than once-daily somatropin injections. • The safety of weekly somatrogon was similar to that of daily somatropin. • Compared with daily somatropin injections, children with growth hormone deficiency may be less likely to miss weekly somatrogon injections. ○ This is because weekly somatrogon injections were less of a burden and were less likely to interfere with daily activities compared with daily somatropin injections. The purpose of this plain language summary is to help you to understand the findings from recent research. • Somatrogon is used to treat the condition under study that is discussed in this summary. Approval varies by country; please check with your local provider for more details. • The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study. This original scientific article on which this summary is based was published in the Journal of the Endocrine Society and can be accessed for free at: https://academic.oup.com/jes/article/6/10/bvac117/6695276. The details of the original article are as follows: Aristides K. Maniatis, Mauri Carakushansky, Sonya Galcheva, Gnanagurudasan Prakasam, Larry A. Fox, Adriana Dankovcikova, Jane Loftus, Andrew A. Palladino, Maria de los Angeles Resa, Carrie Turich Taylor, Mehul T. Dattani, Jan Lebl. Treatment burden of weekly somatrogon versus daily somatropin in children with growth hormone deficiency: a randomized study. J Endocr Soc 2022; 6(10): bvac117. DOI: 10.1210/jendso/bvac117.

    Published in:
    Therapeutic Advances in Endocrinology & Metabolism, 2024, p. 1, doi. 10.1177/20420188241274363
    By:
    • Maniatis, Aristides K.;
    • Carakushansky, Mauri;
    • Galcheva, Sonya;
    • Prakasam, Gnanagurudasan;
    • Fox, Larry A.;
    • Dankovcikova, Adriana;
    • Loftus, Jane;
    • Palladino, Andrew A.;
    • Resa, Maria de los Angeles;
    • Taylor, Carrie Turich;
    • Dattani, Mehul T.;
    • Lebl, Jan
    Publication type:
    Article
    12
    13
    14
    15

    Response to Letter to the Editor From Chatelain et al: 'Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial'.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. e647, doi. 10.1210/clinem/dgad095
    By:
    • Miller, Bradley S.;
    • Blair, Joanne C.;
    • Rasmussen, Michael Højby;
    • Maniatis, Aristides;
    • Kildemoes, Rasmus Juul;
    • Jun Mori;
    • Polak, Michel;
    • Bang, Rikke Beck;
    • Böttcher, Volker;
    • Stagi, Stefano;
    • Reiko Horikawa
    Publication type:
    Article
    16
    17

    Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 7, p. e2680, doi. 10.1210/clinem/dgac217
    By:
    • Maniatis, Aristides K.;
    • Casella, Samuel J.;
    • Nadgir, Ulhas M.;
    • Hofman, Paul L.;
    • Saenger, Paul;
    • Chertock, Elena D.;
    • Aghajanova, Elena M.;
    • Korpal-Szczyrska, Maria;
    • Vlachopapadopoulou, Elpis;
    • Malievskiy, Oleg;
    • Chaychenko, Tetyana;
    • Cappa, Marco;
    • Wenjie Song;
    • Meng Mao;
    • Mygind, Per Holse;
    • Smith, Alden R.;
    • Chessler, Steven D.;
    • Komirenko, Allison S.;
    • Beckert, Michael;
    • Shu, Aimee D.
    Publication type:
    Article
    18

    Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e2215, doi. 10.1210/clinem/dgab879
    By:
    • Thornton, Paul S.;
    • Maniatis, Aristides K.;
    • Aghajanova, Elena;
    • Chertok, Elena;
    • Zhengning Lin;
    • Wenjie Song;
    • Christoffersen, Eva Dam;
    • Breinholt, Vibeke Miller;
    • Giorgadze, Elene;
    • Korpal-Szczyrska, Maria;
    • Hofman, Paul L.;
    • Karpf, David B.;
    • Shu, Aimee D.;
    • Beckert, Michael
    Publication type:
    Article
    19

    Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 3, p. e1333, doi. 10.1210/clinem/dgab738
    By:
    • Thornton, Paul S.;
    • Maniatis, Aristides K.;
    • Aghajanova, Elena;
    • Chertok, Elena;
    • Vlachopapadopoulou, Elpis;
    • Zhengning Lin;
    • Wenjie Song;
    • Christoffersen, Eva Dam;
    • Breinholt, Vibeke Miller;
    • Kovalenko, Tatiana;
    • Giorgadze, Elene;
    • Korpal-Szczyrska, Maria;
    • Hofman, Paul L.;
    • Karpf, David B.;
    • Shu, Aimee D.;
    • Beckert, Michael
    Publication type:
    Article
    20

    Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.

    Published in:
    2021
    By:
    • Thornton, Paul S.;
    • Maniatis, Aristides K.;
    • Aghajanova, Elena;
    • Chertok, Elena;
    • Vlachopapadopoulou, Elpis;
    • Zhengning Lin;
    • Wenjie Song;
    • Christoffersen, Eva Dam;
    • Breinholt, Vibeke Miller;
    • Tatiana Kovalenko;
    • Giorgadze, Elene;
    • Korpal-Szczyrska, Maria;
    • Hofman, Paul L.;
    • Karpf, David B.;
    • Shu, Aimee D.;
    • Beckert, Michael;
    • Lin, Zhengning;
    • Song, Wenjie;
    • Kovalenko, Tatiana
    Publication type:
    journal article